Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKesson
McKinsey
Johnson and Johnson
Moodys
Medtronic
Dow

Last Updated: October 20, 2019

DrugPatentWatch Database Preview

Quantum Pharmics Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for QUANTUM PHARMICS, and what generic and branded alternatives to QUANTUM PHARMICS drugs are available?

QUANTUM PHARMICS has sixty-three approved drugs.



Summary for Quantum Pharmics
US Patents:0
Tradenames:25
Ingredients:23
NDAs:63

Drugs and US Patents for Quantum Pharmics

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Quantum Pharmics TEMAZ temazepam CAPSULE;ORAL 070564-001 Oct 15, 1985 DISCN No No   Start Trial   Start Trial
Quantum Pharmics Q-GESIC aspirin; meprobamate TABLET;ORAL 088740-001 Jun 1, 1984 DISCN No No   Start Trial   Start Trial
Quantum Pharmics HYDROXYZINE HYDROCHLORIDE hydroxyzine hydrochloride TABLET;ORAL 088540-001 Oct 22, 1985 DISCN No No   Start Trial   Start Trial
Quantum Pharmics Q-PAM diazepam TABLET;ORAL 070425-001 Dec 12, 1985 DISCN No No   Start Trial   Start Trial
Quantum Pharmics FENOPROFEN CALCIUM fenoprofen calcium CAPSULE;ORAL 071738-001 Aug 17, 1988 DISCN No No   Start Trial   Start Trial
Quantum Pharmics DOXEPIN HYDROCHLORIDE doxepin hydrochloride CAPSULE;ORAL 070931-001 Sep 29, 1987 DISCN No No   Start Trial   Start Trial
Quantum Pharmics DOXEPIN HYDROCHLORIDE doxepin hydrochloride CAPSULE;ORAL 072376-001 Mar 15, 1989 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Moodys
Baxter
Express Scripts
McKinsey
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.